España
India
Italia
대한민ęµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민ęµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Dynavax Technologies
DVAX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$13.69
0.28
2.09%
At close: -
$13.69
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Q4 2024 Earnings were released on Thu Feb 20th, after the market close
The most recent conference call was at 16:30 PM, 6 days ago
Click to view past webcast
Dynavax Technologies (DVAX) Forecast
News
Earnings
Dynavax Technologies (DVAX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Dynavax Technologies (NASDAQ:DVAX) Stock
Dynavax Technologies Stock (NASDAQ: DVAX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 21, 2025
Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights
Citizens Capital Markets Maintains Market Out...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk
Thursday, February 20, 2025
Dynavax Technologies Q4 GAAP EPS $0.05 Beats ...
Benzinga Newsdesk
Earnings Scheduled For February 20, 2025
Benzinga Insights
Wednesday, February 19, 2025
Dynavax Confirms That Deep Track Capital Subm...
Benzinga Newsdesk
Tuesday, February 11, 2025
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
Vandana Singh
Dynavax shares are trading lower after Goldma...
Benzinga Newsdesk
This Columbus McKinnon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Avi Kapoor
Goldman Sachs Downgrades Dynavax Technologies...
Benzinga Newsdesk
Tuesday, January 14, 2025
HC Wainwright & Co. Maintains Buy on Dynavax ...
Benzinga Newsdesk
Monday, January 13, 2025
Dynavax Prelim. 2024 HEPLISAV-B Net Product R...
Benzinga Newsdesk
Monday, November 11, 2024
Dynavax Announces $100M Accelerated Share Rep...
Benzinga Newsdesk
Friday, November 08, 2024
Dynavax Technologies shares are trading highe...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk
Thursday, November 07, 2024
Dynavax Launches $200M Share Buyback Program ...
Benzinga Newsdesk
Dynavax Technologies Q3 2024 GAAP EPS $0.12 B...
Benzinga Newsdesk
Wednesday, November 06, 2024
Insights into Dynavax Technologies's Upcoming Earnings
Benzinga Insights
Tuesday, October 29, 2024
Dynavax Adopts Limited-Duration Stockholder R...
Benzinga Newsdesk
Tuesday, October 15, 2024
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk
Thursday, August 08, 2024
Assessing Dynavax Technologies: Insights From 4 Financial Analysts
Benzinga Insights
Goldman Sachs Maintains Neutral on Dynavax Te...
Benzinga Newsdesk
Wednesday, August 07, 2024
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk
Tuesday, August 06, 2024
Dynavax Reaffirms 2024 HEPLISAV-B Net Product...
Benzinga Newsdesk
Dynavax Technologies Q2 2024 GAAP EPS $0.08 B...
Benzinga Newsdesk
Friday, August 02, 2024
Dynavax Reappoints Kelly MacDonald As CFO Eff...
Benzinga Newsdesk
Friday, June 28, 2024
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk
Thursday, June 27, 2024
Dynavax Initiates Phase 1/2 Study Of Novel Sh...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
Vandana Singh
FDA Issued Complete Response Letter To Dynava...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk
Wednesday, May 08, 2024
Dynavax shares are trading lower after the co...
Benzinga Newsdesk
Dynavax Reaffirms Full Year 2024 Financial Gu...
Benzinga Newsdesk
Dynavax Technologies Q1 2024 GAAP EPS $(0.07)...
Benzinga Newsdesk
Thursday, February 22, 2024
Dynavax Technologies Sees FY24 Net Product Re...
Benzinga Newsdesk
Dynavax Technologies: Q4 Earnings Insights
Benzinga Insights
Dynavax Technologies Q4 Sales $55.60M Beat $5...
Benzinga Newsdesk
Earnings Scheduled For February 22, 2024
Benzinga Insights
Thursday, February 01, 2024
Goldman Sachs Initiates Coverage On Dynavax T...
Benzinga Newsdesk
Monday, January 08, 2024
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Dynavax Technologies shares are trading lower...
Benzinga Newsdesk
Dynavax Sees Prelim. 2023 HEPLISAV-B Vaccine ...
Benzinga Newsdesk
Friday, November 03, 2023
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Dynavax ...
Benzinga Newsdesk
Thursday, November 02, 2023
Dynavax Technologies Q3 EPS $0.10, Sales $69....
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Wednesday, November 01, 2023
Earnings Preview For Dynavax Technologies
Benzinga Insights
Thursday, September 07, 2023
Cramer Suggests Buying Fast Food Chain Owner Of Popeye's, Burger King: Here's Why
Lisa Levin
Wednesday, August 09, 2023
Chief Accounting Officer at Dynavax Technologies Exercises Options Worth $117K
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
